Radiofrequency and Myofascial Pain Syndrome in Postpartum Pelvic Pain

Launched by UNIVERSITY OF ALCALA · Jun 17, 2024

Keywords

ClinConnect Summary

This clinical trial is investigating how effective a specialized physiotherapy treatment can be in relieving pelvic pain in women who have recently given birth. Many women experience discomfort in the pelvic area after vaginal delivery, which can sometimes make sexual activity painful. The trial aims to see if a combination of education about pelvic health, exercises for the pelvic floor muscles, and a treatment called radiofrequency can help reduce this pain and improve sexual function. The study will include 38 women in each of two groups: one will receive the physiotherapy treatment without radiofrequency, and the other will receive the same treatment with the addition of radiofrequency.

To participate in this trial, women must be first-time mothers who have experienced pelvic pain at least eight weeks after a vaginal birth, with a pain level of 4 or higher on a simple scale. Women who have had multiple births, cesarean sections, or certain medical conditions will not be eligible. Participants can expect to attend 12 supervised physiotherapy sessions over several months, during which their pain levels and quality of life will be assessed. Additionally, some participants will be interviewed to share their experiences with the treatment. This study aims to provide valuable insights into effective treatments for postpartum pelvic pain.

Gender

FEMALE

Eligibility criteria

• Inclusion Criteria:
• • Primiparous women
• • Eutocic vaginal birth
• • Postpartum pelviperineal pain 8 weeks after birth
• • Intensity ≥ 4 cm in the VAS
• • Freely signed the Informed consent
• Exclusion Criteria:
• • Multiparous women
• • Instrumental delivery
• • Cesarean delivery
• • Avulsion of the levator ani muscle
• • Diagnosis of coccygodynia and/or coccygeal pain
• • Sphincter anal injury during vaginal birth
• • History of pelvic fractures and/or neoplasms
• • Pregnant women
• • Neurological diseases
• • Vaginal infection or active urinary tract, or with any
• • Uterine device with metallic components
• • Women with cognitive, auditory and/or visual limitations to understand information, respond to questionnaires, consent and/or participate in the study.